Cargando…
Molecular docking and dynamic simulation of approved drugs targeting against spike protein (6VXX) of 2019-nCoV (novel coronavirus)
The 2019-nCoV has triggered a global public health emergency due to its rapid spread, resulting in a pandemic situation. Because of its ability to bind with the host cell receptor ACE-2, the spike protein of the 2019-nCoV is a critical factor in viral infection. The current study aims to investigate...
Autores principales: | Thakur, Abhinay, Bansode, Dikshita, Ghare, Pragati, Sakpal, Shrutika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Indian Chemical Society. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197568/ http://dx.doi.org/10.1016/j.jics.2022.100571 |
Ejemplares similares
-
Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines
por: Liu, Xin, et al.
Publicado: (2020) -
Return of the Coronavirus: 2019-nCoV
por: Gralinski, Lisa E., et al.
Publicado: (2020) -
Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus
por: Odhar, Hasanain Abdulhameed, et al.
Publicado: (2020) -
2019 Novel Coronavirus (2019-nCoV) Pneumonia
por: Liu, Peng, et al.
Publicado: (2020) -
Containing 2019-nCoV (Wuhan) coronavirus
por: Kaplan, Edward H.
Publicado: (2020)